Cargando…
Endoscopic anti-reflux therapy for gastroesophageal reflux disease
Gastroesophageal reflux disease has an increasing incidence and prevalence worldwide. A significant proportion of patients have a suboptimal response to proton pump inhibitors or are unwilling to take lifelong medication due to concerns about long-term adverse effects. Endoscopic anti-reflux therapi...
Autores principales: | Rodríguez de Santiago, Enrique, Albéniz, Eduardo, Estremera-Arevalo, Fermin, Teruel Sanchez-Vegazo, Carlos, Lorenzo-Zúñiga, Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554403/ https://www.ncbi.nlm.nih.gov/pubmed/34754155 http://dx.doi.org/10.3748/wjg.v27.i39.6601 |
Ejemplares similares
-
Focus on gastroesophageal reflux disease in patients with cystic fibrosis
por: Bongiovanni, Annarita, et al.
Publicado: (2020) -
Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022) -
Risk factors for gastroesophageal reflux disease and analysis of genetic contributors
por: Argyrou, Alexandra, et al.
Publicado: (2018) -
Proposed approach to the challenging management of progressive gastroesophageal reflux disease
por: Labenz, Joachim, et al.
Publicado: (2018) -
Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis
por: Rodríguez de Santiago, Enrique, et al.
Publicado: (2021)